ELUVIXTAMAB
UNII 6Z4B5PJ4OP

Substance Identification & Data

This profile provides standardized clinical and technical data for Eluvixtamab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 6Z4B5PJ4OP.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1679391-73-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
6Z4B5PJ4OP
CAS Registry Number
1679391-73-1
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ELUVIXTAMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
11240
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
JK-133
Identifier assigned by the United States Adopted Names Council.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Eluvixtamab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ELUVIXTAMAB

Common Names & Synonyms

A CD33/CD3 BISPECIFIC T-CELL ENGAGER ANTIBODY FOR ACUTE MYELOID LEUKEMIA THERAPY
ELUVIXTAMAB [INN]
ELUVIXTAMAB [USAN]
IMMUNOGLOBULIN, ANTI-(HUMAN SIALIC ACID-BINDING IG-LIKE LECTIN 3) (HUMAN MONOCLONAL 1803MNGSSMABC SINGLE-CHAIN VARIABLE FRAGMENT VH1-(GGGGS)3-VL1) FUSION PROTEIN WITH PEPTIDE LINKER (GGGGS) FUSION PROTEIN WITH IMMUNOGLOBULIN ANTI-(HUMAN CD3 ANTIGEN .EPSILON.-CHAIN) (HUMAN MONOCLONAL 1803MNGSSMABC SINGLE-CHAIN VARIABLE FRAGMENT VH2-(GGGGS)3-VL2)

Technical Codes

AMG330
AMG-330